Classification of Background Parenchymal Uptake on Molecular Breast Imaging Using a Convolutional Neural Network

JCO Clin Cancer Inform. 2019 Feb:3:1-11. doi: 10.1200/CCI.18.00133.

Abstract

Purpose: Background parenchymal uptake (BPU), which describes the level of radiotracer uptake in normal fibroglandular tissue on molecular breast imaging (MBI), has been identified as a breast cancer risk factor. Our objective was to develop and validate a deep learning model using image convolution to automatically categorize BPU on MBI.

Methods: MBI examinations obtained for clinical and research purposes from 2004 to 2015 were reviewed to classify the BPU pattern using a standardized five-category scale. Two expert radiologists provided interpretations that were used as the reference standard for modeling. The modeling consisted of training and validating a convolutional neural network to predict BPU. Model performance was summarized in data reserved to test the performance of the algorithm at the per-image and per-breast levels.

Results: Training was performed on 24,639 images from 3,133 unique patients. The model performance on the withheld testing data (6,172 images; 786 patients) was evaluated. Using direct matching on the predicted classification resulted in an accuracy of 69.4% (95% CI, 67.4% to 71.3%), and if prediction within one category was considered, accuracy increased to 96.0% (95% CI, 95.2% to 96.7%). When considering the breast-level prediction of BPU, the accuracy remained strong, with 70.3% (95% CI, 68.0% to 72.6%) and 96.2% (95% CI, 95.3% to 97.2%) for the direct match and allowance for one category, respectively.

Conclusion: BPU provided a robust target for training a convolutional neural network. A validated computer algorithm will allow for objective, reproducible encoding of BPU to foster its integration into risk-stratification algorithms.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Breast / diagnostic imaging
  • Breast / metabolism
  • Breast / pathology
  • Breast Neoplasms / diagnostic imaging*
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology
  • Female
  • Humans
  • Image Interpretation, Computer-Assisted / methods*
  • Mammography / methods*
  • Molecular Imaging / methods*
  • Neural Networks, Computer*
  • Parenchymal Tissue / diagnostic imaging*
  • Parenchymal Tissue / metabolism*
  • Parenchymal Tissue / pathology
  • Radionuclide Imaging / methods
  • Radiopharmaceuticals / pharmacokinetics*
  • Risk Assessment
  • Risk Factors

Substances

  • Radiopharmaceuticals